澳大利亚正在使用Orthhocell的Remplir神经修复装置来改善前列腺外科手术后的恢复,美国计划扩大手术范围。 Orthocell's Remplir nerve repair device is being used in Australia to improve recovery after prostate surgery, with U.S. expansion planned.

澳大利亚再生医学公司Orthhocell引进了神经修复装置Remplir,用于澳大利亚神经分离机器人辅助前列腺外科手术,在大约40个程序中使用了该装置,以帮助改善立体功能和尿欲耐用性恢复。 Australian regenerative medicine company Orthocell has introduced its nerve repair device, Remplir, for use in nerve-sparing robotic-assisted prostate surgery in Australia, where it has been used in about 40 procedures to help improve erectile function and urinary continence recovery. 该公司正在从这些病例中收集临床数据,如果有结果,将予以公布,并计划开展进一步的研究,以支持医学教育和扩大该装置的市场。 The company is collecting clinical data from these cases, with results to be released when available, and plans further research to support medical education and expand the device’s market. 雷普利尔旨在保护手术期间的神经并促进恢复, 推出在美国市场的进展, 估值为16亿美元. Remplir aims to protect nerves during surgery and promote recovery, with rollout progressing in the U.S. market, which is valued at $1.6 billion.